ClinicalTrials.gg

ZARS Pharma Inc. clinical trials

The registry lists 24 studies whose lead sponsor is ZARS Pharma Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 17, 2012.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

What it is testing

The drugs ZARS Pharma Inc.’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 24 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed1979%
  • Stopped early521%Terminated 4 · Suspended 1

Phase

  • Phase 312
  • Phase 29
  • Phase 42
  • Phase 11

Where

  • United States24

Over the years

  1. 07
  2. 08
  3. 09
  4. 410
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 026

By the year each study started; 13 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to ZARS Pharma Inc..

  • ZARS Pharma Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies

Focus areas

Conditions ZARS Pharma Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 24 of 24.